UFPT
Ufp Technologies Inc Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$284.50Close
$2.2BMarket cap
$185.28 – $334.8452-week range
Nov 2, 2026Next report
Highlights
Strengths
- Leading the market RS 81 · stronger than 81% of stocks over 12 months
- Earnings growing EPS +21% year on year, faster than the quarter before (+20 pts)
Cautions
- Trend not confirmed 7 of 8 conditions · under the 50-day
- Results soon Nov 2, 2026, in 1 day
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
15%
1wk
down 3.8%
price change
1mo
down 4.2%
price change
12-month return
up 54%
market up 11% ·
its own up 39%
F-score
6 / 9
Mixed
Altman Z
8.09
Low risk
P/E
32.0×
price / earnings
PEG
2.06
P/E / EPS growth
P/B
5.2×
price / book
Earnings yield
up 4.0%
EBIT / enterprise value
Cheaper than
50%
of the market · around average
Revenue growth
up 20%
year on year
EPS growth
up 21%
latest quarter · +20 pts
Sales growth
up 15%
latest quarter · +11 pts
ROE
up 18%
return on equity
Free cash margin
up 15%
$91.9M FCF
D/E
0.29
long-term debt / equity
Net debt / EBITDA
0.9×
Interest cover
—EBIT / interest
Piotroski tests
- profitability slipped from last year
- gross margin narrowed
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
- no new shares issued
Repair signals
- Long-term debt down 30% ($0.2B → $0.1B)
Trade setup
ATR%
3.3%
$9.37 a day · 2×ATR $265.77
RS
81 / 99
vs the universe
Trend
7 / 8
under the 50-day
Relative volume
0.8×
vs 50-day average
Up/down volume
0.80
50 sessions
Implied move
—
no option chain · report Nov 2, 2026
Trend template · 7 of 8
- Price above the 50-day average: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Aug 3, 2026
Results reaction
Aug 3, 2026+28% vs market2 sessions after results
Financials
- Gross 28%
- Net 11%
- Free cash 15%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $179.4M | $206.3M | $353.8M | $400.1M | $504.4M | $602.8M |
| Gross margin | 25% | 25% | 26% | 28% | 29% | 28% |
| Operating income | $16.7M | $21.2M | $55.4M | $57.7M | $80.9M | $92.3M |
| Net income | $13.4M | $15.9M | $41.8M | $44.9M | $59.0M | $68.3M |
| Net margin | 7% | 8% | 12% | 11% | 12% | 11% |
| Earnings per share | $1.77 | $2.09 | $5.45 | $5.83 | $7.58 | $8.75 |
| Free cash flow | $20.7M | $8.9M | $4.0M | $30.8M | $56.9M | $91.9M |
| Free cash margin | 12% | 4% | 1% | 8% | 11% | 15% |
| Cash | $24.2M | $11.1M | $4.5M | $5.3M | $13.4M | $20.3M |
| Long-term debt | $0 | $71.0M | $51.0M | $28.0M | $176.9M | $123.0M |
| Shareholders' equity | $176.9M | $194.4M | $237.5M | $286.1M | $342.8M | $423.9M |
| Shares outstanding | 7.50m | 7.58m | 7.64m | 7.64m | 7.68m | 7.68m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 8, 2026 | Quarterly ↗ | Mar 31, 2026 | 38d |
| Feb 27, 2026 | Annual ↗ | Dec 31, 2025 | 58d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 11, 2025 | Quarterly ↗ | Jun 30, 2025 | 42d |
| May 12, 2025 | Quarterly ↗ | Mar 31, 2025 | 42d |
| Mar 3, 2025 | Annual ↗ | Dec 31, 2024 | 62d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 10, 2024 | Quarterly ↗ | Mar 31, 2024 | 40d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 24, 2026 | Regulation FD ↗ |
| Aug 3, 2026 | Results ↗ |
| Jun 10, 2026 | Director or officer change · Regulation FD ↗ |
| Jun 8, 2026 | Regulation FD ↗ |
| Jun 5, 2026 | Shareholder vote ↗ |
| May 26, 2026 | Director or officer change ↗ |
| May 4, 2026 | Results ↗ |
| Feb 27, 2026 | Regulation FD ↗ |
| Feb 24, 2026 | Material agreement ↗ |
| Feb 24, 2026 | Cybersecurity incident ↗ |
| Feb 24, 2026 | Results ↗ |
| Feb 13, 2026 | Director or officer change ↗ |